The Effect of Blood Flow Restriction Training on Hamstring Elasticity After Injury
Launched by UNIVERSITY GHENT · Jan 27, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific type of exercise called Blood Flow Restriction Training (BFRT) can help improve the flexibility of the hamstring muscle after an injury, specifically for football players who have recently strained their hamstring. Participants will be divided into three groups: one group will receive standard rehabilitation along with BFRT, another group will receive standard rehabilitation with a fake version of BFRT, and the third group will only get standard rehabilitation. The goal is to see how well each approach helps with recovery over time.
To be eligible for this trial, participants must be male adults aged 18 to 35 who have suffered an acute hamstring strain injury. Those with a history of hamstring injuries, recent severe injuries or surgeries on the leg, or certain health issues that prevent safe participation will not be included. Throughout the study, participants will undergo several assessments, including MRI scans and special measurements to track the healing of their injured hamstring. They will also have regular follow-ups for six months to check for any re-injuries. This research aims to find the best ways to help athletes recover quickly and safely from hamstring injuries.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Acute hamstring strain injury
- • Male
- • Adult (18+) between 18 and 35 years old
- Exclusion Criteria:
- • History of hamstring injuries
- • Recent severe trauma or surgery in the lower extremity
- • Any contra-indication for occluding vascular flow (such as hypertension, risk factors for and/or history of cardiovascular pathologies or thromboembolism, surgery, fractures, severe obesity,...)
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Trial Officials
Erik Witvrouw, Prof. dr.
Principal Investigator
Department of Rehabilitation Sciences, Ghent University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials